A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation
Open Access
- 14 January 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 11 (6), 1562-1581
- https://doi.org/10.1158/2159-8290.CD-20-1109
Abstract
Mutations in ARID1A rank among the most common molecular aberrations in human cancer. However, oncogenic consequences of ARID1A mutation in human cells remain poorly defined due to lack of forward genetic models. Here, CRISPR/Cas9-mediated ARID1A knockout (KO) in primary TP53(-/-) human gastric organoids induced morphologic dysplasia, tumorigenicity, and mucinous differentiation. Genetic WNT/beta-catenin activation rescued mucinous differentiation, but not hyperproliferation, suggesting alternative pathways of ARID1A KO-mediated transformation. ARID1A mutation induced transcriptional regulatory modules characteristic of microsatellite instability and Epstein-Barr virus-associated subtype human gastric cancer, including FOXM1-associated mitotic genes and BIRC5/survivin. Convergently, high-throughput compound screening indicated selective vulnerability of ARID1A-deficient organoids to inhibition of BIRC5/survivin, functionally implicating this pathway as an essential mediator of ARID1A KO-dependent early-stage gastric tumorigenesis. Overall, we define distinct pathways downstream of oncogenic ARID1A mutation, with nonessential WNT-inhibited mucinous differentiation in parallel with essential transcriptional FOXM1/BIRC5-stimulated proliferation, illustrating the general utility of organoid-based forward genetic cancer analysis in human cells. SIGNIFICANCE: We establish the first human forward genetic modeling of a commonly mutated tumor suppressor gene, ARID1A. Our study integrates diverse modalities including CRISPR/Cas9 genome editing, organoid culture, systems biology, and small-molecule screening to derive novel insights into early transformation mechanisms of ARID1A-deficient gastric cancers.Other Versions
Funding Information
- NIH (K00CA212433)
- Swedish Research Council International Postdoctoral Fellowship
- NIH (R00GM134154)
- NIH (U01CA217875)
- NIH (R35 CA197745, S10 OD012351, S10 OD021764)
This publication has 88 references indexed in Scilit:
- BAF complexes facilitate decatenation of DNA by topoisomerase IIαNature, 2013
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancyNature Genetics, 2013
- Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial SarcomaCell, 2013
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic TransformationCancer Cell, 2010
- SAM pointed domain ETS factor (SPDEF) regulates terminal differentiation and maturation of intestinal goblet cellsExperimental Cell Research, 2010
- Chromatin remodelling during developmentNature, 2010
- Understanding the Words of Chromatin RegulationCell, 2009
- Reverse engineering of regulatory networks in human B cellsNature Genetics, 2005
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003